| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:296.)
© 2002 American Heart Association, Inc.
Brief Rapid Communications |
From the Department of Medicine (W.Y.K., M.S., W.J.M, R.M.B.), Cardiovascular Division, and the Department of Radiology (W.J.M.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass; The MR-Center, Department of Cardiology (W.Y.K.) and Institute of Experimental Clinical Research, Aarhus University Hospital, Skejby Sygehus, Denmark; Philips Medical Systems (M.S., R.M.B.), Best, the Netherlands; and Philips Research Laboratories (P.B.), Hamburg, Germany.
Correspondence to René M. Botnar, PhD, Beth Israel Deaconess Medical Center, Cardiovascular Division, Cardiac MR Center 330 Brookline Ave, Boston, MA, 02215. E-mail rbotnar{at}caregroup.harvard.edu
| Abstract |
|---|
|
|
|---|
Methods and Results Twelve adult subjects, including 6 clinically healthy subjects and 6 patients with nonsignificant coronary artery disease (10% to 50% x-ray angiographic diameter reduction) were studied with the use of a commercial 1.5 Tesla CMR scanner. Free-breathing 3D coronary vessel wall imaging was performed along the major axis of the right coronary artery with isotropic spatial resolution (1.0x1.0x1.0 mm3) with the use of a black-blood spiral image acquisition. The proximal vessel wall thickness and luminal diameter were objectively determined with an automated edge detection tool. The 3D CMR vessel wall scans allowed for visualization of the contiguous proximal right coronary artery in all subjects. Both mean vessel wall thickness (1.7±0.3 versus 1.0±0.2 mm) and wall area (25.4±6.9 versus 11.5±5.2 mm2) were significantly increased in the patients compared with the healthy subjects (both P<0.01). The lumen diameter (3.6±0.7 versus 3.4±0.5 mm, P=0.47) and lumen area (8.9±3.4 versus 7.9±3.5 mm2, P=0.47) were similar in both groups.
Conclusions Free-breathing 3D black-blood coronary CMR with isotropic resolution identified an increased coronary vessel wall thickness with preservation of lumen size in patients with nonsignificant coronary artery disease, consistent with a "Glagov-type" outward arterial remodeling. This novel approach has the potential to quantify subclinical disease.
Key Words: atherosclerosis plaque vessels magnetic resonance imaging
| Introduction |
|---|
|
|
|---|
We have recently implemented a black-blood three-dimensional (3D) cardiovascular magnetic resonance (CMR) sequence with isotropic image resolution to enable vessel wall imaging along the major axis of the proximal coronary arteries.5 In the present study, we sought to determine whether this novel approach can detect outward arterial remodeling (by means of an increased coronary wall thickness) in patients with subclinical CAD.
| Methods |
|---|
|
|
|---|
CMR Imaging Procedure
The CMR examination was performed on a commercial 1.5 Tesla system (Gyroscan ACS-NT 15, Philips Medical Systems) equipped with PowerTrak 6000 gradients (23 mT/m, 219 µs rise time). All subjects were examined in the supine position with the use of a commercial 5-element cardiac synergy receiver coil. All coronary scans were performed with cardiac synchronization during free breathing with the use of a navigator technique.6
Localization of the Coronary Arteries
A plane through the major axis of the proximal RCA was identified with the use of a 3-point planscan tool to define the course of the proximal coronary arteries as depicted from a transverse 3D scan positioned about the base of the heart.7
Three-Dimensional Coronary MRA
Double oblique 3D bright-blood coronary MRA of the RCA was performed along the formerly identified long axis of the proximal coronary artery by use of an ECG-gated TFE/EPI sequence (repetition time [TR]=16 ms, echo time [TE]=5.1 ms, 3 excitations per shot, flip angle=40°, EPI factor=7, acquisition window 33 ms, field of view [FOV]=340 mm, scan matrix=256x177, in-plane resolution=1.3x1.9 mm2, reconstructed slice thickness 1.5 mm, 21 slices).8 The total acquisition time for this scan was
3 minutes.
Three-Dimensional CMR Vessel Wall Imaging
The black-blood 3D CMR wall scan was performed in the same imaging plane as the 3D bright-blood coronary MRA. The black-blood properties were obtained with a modified local dual-inversion prepulse to null signal from blood and surrounding tissue.5 To suppress the signal from epicardial fat, a frequency-selective fat suppression prepulse was applied. A 3D spiral imaging sequence5 was used for the vessel wall imaging (TR=30 ms, TE=2 ms, acquisition window 60 ms, 26 slices with a thickness of 1 to 2 mm, FOV 400 to 512 mm, acquisition matrix 512x512, in-plane resolution 0.78 to 1.0x0.78 to 1.0 mm). The imaging time for this scan was
15 minutes.
Coronary Vessel Wall and Lumen Evaluation
For evaluation of the coronary vessel wall and lumen size, the 3D CMR vessel wall and coronary MRA datasets were reformatted along the major axis of the RCA on a commercial workstation (EasyVision 4.0, Philips Medical Systems). To minimize digitization errors and facilitate data analysis, the images were zoomed by a factor of 4 with the use of a fast Fourier transform algorithm.9 The average proximal vessel wall thickness and average luminal diameter along the entire visualized course of the RCA (inner and outer curvature) (Figures 1 and 2) were objectively determined with an automated edge-detection tool.10
|
|
To visualize the whole circumference of the vessel wall, an animated sequence of cross-sectional views was generated (Movies I and II) from the 3D dataset perpendicular to the major axis of the vessel. On cross-sectional images of the RCA, the inner lumen and outer vessel borders were then manually segmented to determine coronary lumen and wall area.11 The average area values were calculated from 4 equidistant cross-sectional images measured at 10-mm intervals.
Statistics
Continuous variables in patients and healthy subjects were compared with the use of a Wilcoxon rank-sum test, with significance at P
0.05. The wall thickness was correlated by a linear regression analysis to the lumen diameter.
| Results |
|---|
|
|
|---|
The coronary vessel wall appeared distinct from the surrounding epicardial fat and coronary blood (black lumen), and the 2D local dual-inversion pulse effectively suppressed unwanted signals outside the region of interest (Figures 1 and 2). Average signal-to-noise ratio of the RCA wall was similar for patients (35±11) and healthy subjects (36±18, P=0.58). The contrast-to-noise ratio between RCA wall/epicardial fat was 21±7 in the patients and 17±11 in the healthy subjects (P=0.23). The contrast-to-noise ratio between RCA wall/coronary blood was also similar for patients (23±10) and healthy subjects (24±8, P=0.81).
In the healthy subjects, the coronary wall appeared uniformly thin with homogenous signal intensity (Figure 1, Movie I). In the patients, focal thickening of the wall was noted especially at sites corresponding to luminal narrowing on the x-ray angiogram (Figure 2, Movie II).
Both mean vessel wall thickness (Figure 3) (1.7±0.3 versus 1.0±0.2 mm) and wall area (25.4±6.9 versus 11.5±5.2 mm2) were significantly increased in the patients with nonsignificant CAD compared with the healthy subjects (both P<0.01). The lumen diameter (Figure 4) (3.6±0.7 versus 3.4±0.5 mm, P=0.47) and lumen area (8.9±3.4 versus 7.9±3.5 mm2, P=0.47) were similar in patients and healthy subjects. Thus, the ratio of coronary lumen/wall dimension was significantly reduced in the patients compared with healthy subjects (2.1±0.3 versus 3.7±0.9, P<0.01). There was no significant correlation (P=0.14) between vessel wall thickness and coronary MRA lumen diameter for the pooled data.
|
|
| Discussion |
|---|
|
|
|---|
Other investigators who used 2D high-resolution transthoracic echocardiography found a significant increase in the left anterior descending (LAD) vessel wall thickness in patients with CAD compared with healthy subjects.15 Previous studies that used 2D black-blood CMR vessel wall imaging showed the potential of CMR to detect an increased wall thickness and wall area in patients with angiographically significant CAD.11,16 In the present study, we focused on visualization of the RCA, though we have previously demonstrated the feasibility of this CMR approach for the LAD.5 The impact of spatial resolution on CMR evaluation of coronary atherosclerotic plaque burden was investigated showing that the current spatial resolution of 0.8 to 1x0.8 to 1x1 to 2 mm3 is associated with a relative overestimation of the wall area of
30% to 40% in patients versus 50% to 60% in healthy subjects.17 The proximal RCA wall thickness was measured by objective analysis along the entire visualized course and averaged to distinguish sub-pixel changes. The reported values of wall thickness therefore reflect the wall thickness throughout the vessel. The very irregular nature of wall thickening and the presence of minor x-ray angiographic luminal stenosis in all patients suggest that the increased wall thickness represents atherosclerosis. With the use of 2D echocardiography, other investigators have not found any systematic effect of age on wall thickness and external vessel diameter in healthy subjects or patients with CAD.15
Though unproven by the present study, CMR assessment of coronary wall thickness may prove useful for improved risk stratification in individual patients, thereby guiding early treatment and ultimately preventing acute coronary events. In addition, the natural history of coronary atherosclerosis could be studied noninvasively to further our understanding of the complex relationship between arterial remodeling, vessel inflammation, and plaque rupture.
| Footnotes |
|---|
Movies I and II are available in an online-only Data Supplement at http://www.circulationaha.org.
Received April 8, 2002; revision received May 29, 2002; accepted May 29, 2002.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. A. Bluemke, S. Achenbach, M. Budoff, T. C. Gerber, B. Gersh, L. D. Hillis, W. G. Hundley, W. J. Manning, B. F. Printz, M. Stuber, et al. Noninvasive Coronary Artery Imaging: Magnetic Resonance Angiography and Multidetector Computed Tomography Angiography: A Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young Circulation, July 29, 2008; 118(5): 586 - 606. [Full Text] [PDF] |
||||
![]() |
A. S. Astrup, W. Y. Kim, L. Tarnow, R. M. Botnar, C. Simonsen, L. Brix, L. Pietraszek, P. R. Hansen, W. J. Manning, and H.-H. Parving Relation of Left Ventricular Function, Mass, and Volume to NT-proBNP in Type 1 Diabetic Patients Diabetes Care, May 1, 2008; 31(5): 968 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Yeon, A. Sabir, M. Clouse, P. O. Martinezclark, D. C. Peters, T. H. Hauser, C. M. Gibson, R. Nezafat, D. Maintz, W. J. Manning, et al. Delayed-Enhancement Cardiovascular Magnetic Resonance Coronary Artery Wall Imaging: Comparison With Multislice Computed Tomography and Quantitative Coronary Angiography J. Am. Coll. Cardiol., July 31, 2007; 50(5): 441 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saam, T. S. Hatsukami, N. Takaya, B. Chu, H. Underhill, W. S. Kerwin, J. Cai, M. S. Ferguson, and C. Yuan The Vulnerable, or High-Risk, Atherosclerotic Plaque: Noninvasive MR Imaging for Characterization and Assessment Radiology, July 1, 2007; 244(1): 64 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Kim, A. S. Astrup, M. Stuber, L. Tarnow, E. Falk, R. M. Botnar, C. Simonsen, L. Pietraszek, P. R. Hansen, W. J. Manning, et al. Subclinical Coronary and Aortic Atherosclerosis Detected by Magnetic Resonance Imaging in Type 1 Diabetes With and Without Diabetic Nephropathy Circulation, January 16, 2007; 115(2): 228 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Maintz, M. Ozgun, A. Hoffmeier, R. Fischbach, W. Y. Kim, M. Stuber, W. J. Manning, W. Heindel, and R. M. Botnar Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI Eur. Heart J., July 2, 2006; 27(14): 1732 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Desai, S. Lai, C. Barmet, R. G. Weiss, and M. Stuber Reproducibility of 3D free-breathing magnetic resonance coronary vessel wall imaging Eur. Heart J., November 1, 2005; 26(21): 2320 - 2324. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fuster, Z. A. Fayad, P. R. Moreno, M. Poon, R. Corti, and J. J. Badimon Atherothrombosis and High-Risk Plaque: Part II: Approaches by Noninvasive Computed Tomographic/Magnetic Resonance Imaging J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1209 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fuster and R. J. Kim Frontiers in Cardiovascular Magnetic Resonance Circulation, July 5, 2005; 112(1): 135 - 144. [Full Text] [PDF] |
||||
![]() |
D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur. Heart J., November 1, 2004; 25(21): 1940 - 1965. [Full Text] [PDF] |
||||
![]() |
J. A.C. Lima and M. Y. Desai Cardiovascular magnetic resonance imaging: Current and emerging applications J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1164 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Mani, V. V. Itskovich, M. Szimtenings, J. G. S. Aguinaldo, D. D. Samber, G. Mizsei, and Z. A. Fayad Rapid Extended Coverage Simultaneous Multisection Black-Blood Vessel Wall MR Imaging Radiology, July 1, 2004; 232(1): 281 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Achenbach, D. Ropers, U. Hoffmann, B. MacNeill, U. Baum, K. Pohle, T. J. Brady, E. Pomerantsev, J. Ludwig, F. A. Flachskampf, et al. assessment of coronary remodeling in stenotic and nonstenotic coronary atherosclerotic lesions by multidetector spiral computed tomography J. Am. Coll. Cardiol., March 3, 2004; 43(5): 842 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Naghavi, P. Libby, E. Falk, S. W. Casscells, S. Litovsky, J. Rumberger, J. J. Badimon, C. Stefanadis, P. Moreno, G. Pasterkamp, et al. From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part I Circulation, October 7, 2003; 108(14): 1664 - 1672. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Tuzcu and P. Schoenhagen Acute coronary syndromes, plaque vulnerability,and carotid artery disease: The changing role ofatherosclerosis imaging J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1033 - 1036. [Full Text] [PDF] |
||||
![]() |
R. F. Redberg, R. A. Vogel, M. H. Criqui, D. M. Herrington, J. A. C. Lima, and M. J. Roman Task force #3--what is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1886 - 1898. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |